Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

1.0K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.0K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

599
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
599
EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

3.1K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.1K
iPS Cell Differentiation01:22

iPS Cell Differentiation

2.9K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Human iPSC-NSC-Derived Extracellular Vesicles Can Alleviate Alzheimer's Disease-Linked Impairments in Mitochondria, mTOR Signaling, Autophagy, and Hippocampal Neurogenesis.

Aging cell·2026
Same author

Targeting autophagy in lateral habenula for alleviating depression.

Neural regeneration research·2026
Same author

Intranasal Human NSC-Derived EVs Therapy Can Restrain Inflammatory Microglial Transcriptome, and NLRP3 and cGAS-STING Signaling, in Aged Hippocampus.

bioRxiv : the preprint server for biology·2026
Same author

Extracellular vesicles from hiPSC-derived NSCs protect human neurons against Aβ-42 oligomers induced neurodegeneration, mitochondrial dysfunction and tau phosphorylation.

Stem cell research & therapy·2025
Same author

A perspective from the National Eye Institute Extracellular Vesicle Workshop: Gaps, needs, and opportunities for studies of extracellular vesicles in vision research.

Journal of extracellular vesicles·2024
Same author

Residual microglia following short-term PLX5622 treatment in 5xFAD mice exhibit diminished NLRP3 inflammasome and mTOR signaling, and enhanced autophagy.

Aging cell·2024

Related Experiment Video

Updated: Nov 1, 2025

Isolation and Direct Neuronal Reprogramming of Mouse Astrocytes
07:25

Isolation and Direct Neuronal Reprogramming of Mouse Astrocytes

Published on: July 7, 2022

3.0K

Treating Parkinson's disease by astrocyte reprogramming: Progress and challenges.

Zhuang-Yao D Wei1, Ashok K Shetty2

  • 1Department of Molecular and Cellular Medicine, Institute for Regenerative Medicine, Texas A&M University Health Science Center College of Medicine, College Station, TX, USA.

Science Advances
|June 24, 2021
PubMed
Summary

Scientists reprogrammed astrocytes into new dopaminergic neurons in a mouse model of Parkinson's disease (PD). This approach successfully restored dopamine levels, offering a potential new therapy for PD patients.

More Related Videos

In Vivo Direct Reprogramming of Resident Glial Cells into Interneurons by Intracerebral Injection of Viral Vectors
12:26

In Vivo Direct Reprogramming of Resident Glial Cells into Interneurons by Intracerebral Injection of Viral Vectors

Published on: June 17, 2019

9.7K
In vitro Modeling for Neurological Diseases using Direct Conversion from Fibroblasts to Neuronal Progenitor Cells and Differentiation into Astrocytes
11:42

In vitro Modeling for Neurological Diseases using Direct Conversion from Fibroblasts to Neuronal Progenitor Cells and Differentiation into Astrocytes

Published on: June 10, 2021

5.1K

Related Experiment Videos

Last Updated: Nov 1, 2025

Isolation and Direct Neuronal Reprogramming of Mouse Astrocytes
07:25

Isolation and Direct Neuronal Reprogramming of Mouse Astrocytes

Published on: July 7, 2022

3.0K
In Vivo Direct Reprogramming of Resident Glial Cells into Interneurons by Intracerebral Injection of Viral Vectors
12:26

In Vivo Direct Reprogramming of Resident Glial Cells into Interneurons by Intracerebral Injection of Viral Vectors

Published on: June 17, 2019

9.7K
In vitro Modeling for Neurological Diseases using Direct Conversion from Fibroblasts to Neuronal Progenitor Cells and Differentiation into Astrocytes
11:42

In vitro Modeling for Neurological Diseases using Direct Conversion from Fibroblasts to Neuronal Progenitor Cells and Differentiation into Astrocytes

Published on: June 10, 2021

5.1K

Area of Science:

  • Neuroscience
  • Regenerative Medicine

Background:

  • Parkinson's disease (PD) is a prevalent neurodegenerative disorder with motor and nonmotor symptoms.
  • Current PD treatments offer symptomatic relief but do not regenerate lost dopaminergic neurons.

Purpose of the Study:

  • To review astrocyte reprogramming methods for generating new dopaminergic neurons in vivo.
  • To discuss the potential of this approach for Parkinson's disease therapy.

Main Methods:

  • Targeting a microRNA (miRNA) loop to reprogram astrocytes into dopaminergic neurons.
  • Utilizing specific transcription factors and mRNAs for astrocyte reprogramming.

Main Results:

  • Successful in vivo reprogramming of astrocytes into functional dopaminergic neurons in a mouse model of PD.
  • Increased dopamine levels and restored axonal projections in the striatum.

Conclusions:

  • Astrocyte reprogramming shows promise for increasing dopaminergic neurons in the Parkinson's disease brain.
  • Further research is needed to address translational potential, challenges, and risks for clinical application.